Global Neurological Biomarkers Market Size, Status and Forecast 2022
- QYR865278
- 110 Pages
- January 2017
- Pharmaceuticals
Production, means the output of Neurological Biomarkers
Revenue, means the sales value of Neurological Biomarkers
This report studies the global Neurological Biomarkers market, analyzes and researches the Neurological Biomarkers development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
QIAGEN
Myriad RBM
Proteome Sciences
Thermo Fisher Scientific
AbaStar MDx
Abiant
Acumen Pharmaceuticals
Aepodia
Alseres Pharmaceuticals
Athena Diagnostics
Banyan Biomarkers
Cisbio Bioassays
Diagenic ASA
Proteosys
Psynova Neurotech
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Neurological Biomarkers can be split into
Alzheimer's disease
Parkinson’s disease
Autism spectrum disorder
Multiple sclerosis
Market segment by Application, Neurological Biomarkers can be split into
Genomics
Proteomics
Metabolomics
Imaging
Global Neurological Biomarkers Market Size, Status and Forecast 2022
1 Industry Overview of Neurological Biomarkers
1.1 Neurological Biomarkers Market Overview
1.1.1 Neurological Biomarkers Product Scope
1.1.2 Market Status and Outlook
1.2 Global Neurological Biomarkers Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Neurological Biomarkers Market by Type
1.3.1 Alzheimer's disease
1.3.2 Parkinson’s disease
1.3.3 Autism spectrum disorder
1.3.4 Multiple sclerosis
1.4 Neurological Biomarkers Market by End Users/Application
1.4.1 Genomics
1.4.2 Proteomics
1.4.3 Metabolomics
1.4.4 Imaging
2 Global Neurological Biomarkers Competition Analysis by Players
2.1 Neurological Biomarkers Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 QIAGEN
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.1.5 Recent Developments
3.2 Myriad RBM
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.2.5 Recent Developments
3.3 Proteome Sciences
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.3.5 Recent Developments
3.4 Thermo Fisher Scientific
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.4.5 Recent Developments
3.5 AbaStar MDx
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.5.5 Recent Developments
3.6 Abiant
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.6.5 Recent Developments
3.7 Acumen Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.7.5 Recent Developments
3.8 Aepodia
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.8.5 Recent Developments
3.9 Alseres Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.9.5 Recent Developments
3.10 Athena Diagnostics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Neurological Biomarkers Revenue (Value) (2011-2016)
3.10.5 Recent Developments
3.11 Banyan Biomarkers
3.12 Cisbio Bioassays
3.13 Diagenic ASA
3.14 Proteosys
3.15 Psynova Neurotech
4 Global Neurological Biomarkers Market Size by Type and Application (2011-2016)
4.1 Global Neurological Biomarkers Market Size by Type (2011-2016)
4.2 Global Neurological Biomarkers Market Size by Application (2011-2016)
4.3 Potential Application of Neurological Biomarkers in Future
4.4 Top Consumer/End Users of Neurological Biomarkers
5 United States Neurological Biomarkers Development Status and Outlook
5.1 United States Neurological Biomarkers Market Size (2011-2016)
5.2 United States Neurological Biomarkers Market Size and Market Share by Players (2015-2016)
6 EU Neurological Biomarkers Development Status and Outlook
6.1 EU Neurological Biomarkers Market Size (2011-2016)
6.2 EU Neurological Biomarkers Market Size and Market Share by Players (2015-2016)
7 Japan Neurological Biomarkers Development Status and Outlook
7.1 Japan Neurological Biomarkers Market Size (2011-2016)
7.2 Japan Neurological Biomarkers Market Size and Market Share by Players (2015-2016)
8 China Neurological Biomarkers Development Status and Outlook
8.1 China Neurological Biomarkers Market Size (2011-2016)
8.2 China Neurological Biomarkers Market Size and Market Share by Players (2015-2016)
9 India Neurological Biomarkers Development Status and Outlook
9.1 India Neurological Biomarkers Market Size (2011-2016)
9.2 India Neurological Biomarkers Market Size and Market Share by Players (2015-2016)
10 Southeast Asia Neurological Biomarkers Development Status and Outlook
10.1 Southeast Asia Neurological Biomarkers Market Size (2011-2016)
10.2 Southeast Asia Neurological Biomarkers Market Size and Market Share by Players (2015-2016)
11 Market Forecast by Regions, Type and Application (2016-2021)
11.1 Global Neurological Biomarkers Market Size (Value) by Regions (2016-2021)
11.1.1 United States Neurological Biomarkers Revenue and Growth Rate (2016-2021)
11.1.2 EU Neurological Biomarkers Revenue and Growth Rate (2016-2021)
11.1.3 Japan Neurological Biomarkers Revenue and Growth Rate (2016-2021)
11.1.4 China Neurological Biomarkers Revenue and Growth Rate (2016-2021)
11.1.5 India Neurological Biomarkers Revenue and Growth Rate (2016-2021)
11.1.6 Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2016-2021)
11.2 Global Neurological Biomarkers Market Size (Value) by Type (2016-2021)
11.3 Global Neurological Biomarkers Market Size by Application (2016-2021)
12 Neurological Biomarkers Market Dynamics
12.1 Neurological Biomarkers Market Opportunities
12.2 Neurological Biomarkers Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Neurological Biomarkers Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Neurological Biomarkers Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Neurological Biomarkers Product Scope
Figure Global Neurological Biomarkers Market Size (2011-2016)
Table Global Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Global Neurological Biomarkers Market Share by Regions in 2015
Figure United States Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure EU Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Japan Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure China Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure India Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Southeast Asia Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Figure Global Neurological Biomarkers Market Share by Type in 2015
Figure Alzheimer's disease Market Size (Value) and Growth Rate (2011-2016)
Figure Parkinson’s disease Market Size (Value) and Growth Rate (2011-2016)
Figure Autism spectrum disorder Market Size (Value) and Growth Rate (2011-2016)
Figure Multiple sclerosis Market Size (Value) and Growth Rate (2011-2016)
Figure Global Neurological Biomarkers Market Share by Application in 2015
Figure Neurological Biomarkers Market Size and Growth Rate in Genomics (2011-2016)
Figure Neurological Biomarkers Market Size and Growth Rate in Proteomics (2011-2016)
Figure Neurological Biomarkers Market Size and Growth Rate in Metabolomics (2011-2016)
Figure Neurological Biomarkers Market Size and Growth Rate in Imaging (2011-2016)
Table Neurological Biomarkers Market Size (Value) by Players (2015-2016)
Figure Neurological Biomarkers Market Size Share by Players in 2015
Figure Neurological Biomarkers Market Size Share by Players in 2016
Table QIAGEN Basic Information List
Table Neurological Biomarkers Business Revenue of QIAGEN (2011-2016)
Figure QIAGEN Neurological Biomarkers Business Revenue Market Share in 2015
Table Myriad RBM Basic Information List
Table Neurological Biomarkers Business Revenue of Myriad RBM (2011-2016)
Figure Myriad RBM Neurological Biomarkers Business Revenue Market Share in 2015
Table Proteome Sciences Basic Information List
Table Neurological Biomarkers Business Revenue of Proteome Sciences (2011-2016)
Figure Proteome Sciences Neurological Biomarkers Business Revenue Market Share in 2015
Table Thermo Fisher Scientific Basic Information List
Table Neurological Biomarkers Business Revenue of Thermo Fisher Scientific (2011-2016)
Figure Thermo Fisher Scientific Neurological Biomarkers Business Revenue Market Share in 2015
Table AbaStar MDx Basic Information List
Table Neurological Biomarkers Business Revenue of AbaStar MDx (2011-2016)
Figure AbaStar MDx Neurological Biomarkers Business Revenue Market Share in 2015
Table Abiant Basic Information List
Table Neurological Biomarkers Business Revenue of Abiant (2011-2016)
Figure Abiant Neurological Biomarkers Business Revenue Market Share in 2015
Table Acumen Pharmaceuticals Basic Information List
Table Neurological Biomarkers Business Revenue of Acumen Pharmaceuticals (2011-2016)
Figure Acumen Pharmaceuticals Neurological Biomarkers Business Revenue Market Share in 2015
Table Aepodia Basic Information List
Table Neurological Biomarkers Business Revenue of Aepodia (2011-2016)
Figure Aepodia Neurological Biomarkers Business Revenue Market Share in 2015
Table Alseres Pharmaceuticals Basic Information List
Table Neurological Biomarkers Business Revenue of Alseres Pharmaceuticals (2011-2016)
Figure Alseres Pharmaceuticals Neurological Biomarkers Business Revenue Market Share in 2015
Table Athena Diagnostics Basic Information List
Table Neurological Biomarkers Business Revenue of Athena Diagnostics (2011-2016)
Figure Athena Diagnostics Neurological Biomarkers Business Revenue Market Share in 2015
Table Banyan Biomarkers Basic Information List
Table Neurological Biomarkers Business Revenue of Banyan Biomarkers (2011-2016)
Figure Banyan Biomarkers Neurological Biomarkers Business Revenue Market Share in 2015
Table Cisbio Bioassays Basic Information List
Table Neurological Biomarkers Business Revenue of Cisbio Bioassays (2011-2016)
Figure Cisbio Bioassays Neurological Biomarkers Business Revenue Market Share in 2015
Table Diagenic ASA Basic Information List
Table Neurological Biomarkers Business Revenue of Diagenic ASA (2011-2016)
Figure Diagenic ASA Neurological Biomarkers Business Revenue Market Share in 2015
Table Proteosys Basic Information List
Table Neurological Biomarkers Business Revenue of Proteosys (2011-2016)
Figure Proteosys Neurological Biomarkers Business Revenue Market Share in 2015
Table Psynova Neurotech Basic Information List
Table Neurological Biomarkers Business Revenue of Psynova Neurotech (2011-2016)
Figure Psynova Neurotech Neurological Biomarkers Business Revenue Market Share in 2015
Table Global Neurological Biomarkers Market Size by Type (2011-2016)
Figure Global Neurological Biomarkers Market Size Share by Type in 2011
Figure Global Neurological Biomarkers Market Size Share by Type in 2012
Figure Global Neurological Biomarkers Market Size Share by Type in 2013
Figure Global Neurological Biomarkers Market Size Share by Type in 2014
Figure Global Neurological Biomarkers Market Size Share by Type in 2015
Figure Global Neurological Biomarkers Market Size Share by Type in 2016
Table Global Neurological Biomarkers Market Size by Application (2011-2016)
Figure Global Neurological Biomarkers Market Size by Application in 2011
Figure Global Neurological Biomarkers Market Size by Application in 2012
Figure Global Neurological Biomarkers Market Size by Application in 2013
Figure Global Neurological Biomarkers Market Size by Application in 2014
Figure Global Neurological Biomarkers Market Size by Application in 2015
Figure Global Neurological Biomarkers Market Size by Application in 2016
Table Top Consumer/End Users of Neurological Biomarkers
Figure United States Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table United States Neurological Biomarkers Market Size by Players (2011-2016)
Figure United States Neurological Biomarkers Market Size Share by Players in 2015
Figure United States Neurological Biomarkers Market Size Share by Players in 2016
Figure EU Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table EU Neurological Biomarkers Market Size by Players (2011-2016)
Figure EU Neurological Biomarkers Market Size Share by Players in 2015
Figure EU Neurological Biomarkers Market Size Share by Players in 2016
Figure Japan Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table Japan Neurological Biomarkers Market Size by Players (2011-2016)
Figure Japan Neurological Biomarkers Market Size Share by Players in 2015
Figure Japan Neurological Biomarkers Market Size Share by Players in 2016
Figure China Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table China Neurological Biomarkers Market Size by Players (2011-2016)
Figure China Neurological Biomarkers Market Size Share by Players in 2015
Figure China Neurological Biomarkers Market Size Share by Players in 2016
Figure India Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table India Neurological Biomarkers Market Size by Players (2011-2016)
Figure India Neurological Biomarkers Market Size Share by Players in 2015
Figure India Neurological Biomarkers Market Size Share by Players in 2016
Figure Southeast Asia Neurological Biomarkers Market Size and Growth Rate by Regions (2011-2016)
Table Southeast Asia Neurological Biomarkers Market Size by Players (2011-2016)
Figure Southeast Asia Neurological Biomarkers Market Size Share by Players in 2015
Figure Southeast Asia Neurological Biomarkers Market Size Share by Players in 2016
Figure Global Neurological Biomarkers Market Size (Value) by Regions (2016-2021)
Table Global Neurological Biomarkers Market Size by Regions (2016-2021)
Figure Global Neurological Biomarkers Market Size Share by Regions in 2017
Figure Global Neurological Biomarkers Market Size Share by Regions in 2021
Figure United States Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure EU Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure Japan Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure China Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure India Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Figure Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2016-2021)
Table Global Neurological Biomarkers Market Size by Type (2016-2021)
Figure Global Neurological Biomarkers Market Size Share by Type in 2017
Figure Global Neurological Biomarkers Market Size Share by Type in 2021
Table Global Neurological Biomarkers Market Size by Application (2016-2021)
Figure Global Neurological Biomarkers Market Size by Application in 2017
Figure Global Neurological Biomarkers Market Size by Application in 2021
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
